The Delhi government on Wednesday directed all deputy commissioners to not send COVID-19 samples for testing to the National Institute of Biologicals (NIB) in Noida due to "considerable pendency", according to an official order on Wednesday.
The order, issued by Delhi Health Secretary Padmini Singla, stated that the samples shall be distributed among other government and private laboratories to ensure "that the results are received within one day of submission of the sample to the respective lab".
"The samples collected from different districts are being sent to various government and private labs majorly to the National Institute of Biologicals (NIB), Noida (Uttar Pradesh) in the last 15 days.
"And whereas, it has been observed that there is considerable pendency for the testing reports in the National Institute of Biologicals (NIB), which is hindering the effective containment of the disease," the order said.
Till Tuesday, the national capital had recorded 3,314 coronavirus cases.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app